Adaptive Benzathine Analogs for High-Risk Environments

Publication ID: 24-11857550_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Benzathine Analogs for High-Risk Environments,” Published Technical Disclosure No. 24-11857550_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857550_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,550.

Summary of the Inventive Concept

This inventive concept adapts benzathine analogs for treating inflammatory disorders in high-risk environments, such as emergency response situations, high-altitude areas, remote disaster-relief settings, and extreme weather conditions.

Background and Problem Solved

The original patent disclosed benzathine analogs for treating inflammatory disorders. However, these analogs may not be effective or practical in high-risk environments, where unique challenges and constraints exist. This inventive concept addresses the limitations of the original patent by adapting the benzathine analogs for these specific contexts.

Detailed Description of the Inventive Concept

The new inventive concept comprises specialized variations of benzathine analogs, designed to operate effectively in high-risk environments. For example, a portable, waterproof device can administer the compound in emergency response situations. In high-altitude environments, the compound can be formulated to maintain potency despite lower atmospheric pressure. In remote disaster-relief settings, a kit with a manual for administering the compound in low-resource environments can be provided. Additionally, the composition can be stabilized to maintain potency in extreme temperatures, and a wearable, temperature-controlled device can monitor vital signs and adjust the dosage accordingly.

Novelty and Inventive Step

The new claims introduce novel features, such as portability, waterproofing, and high-altitude formulation, which are not obvious from the original patent. These adaptations enable the benzathine analogs to be used effectively in high-risk environments, providing a new and non-obvious solution.

Alternative Embodiments and Variations

Alternative embodiments may include adapting the device for use in extreme temperatures, integrating the wearable device with other vital sign monitoring systems, or developing new formulations for use in specific high-risk environments, such as desert or jungle settings.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of emergency response, disaster relief, and extreme environment operations. The target market includes government agencies, non-governmental organizations, and private companies operating in these high-risk environments.

Original Patent Information

Patent NumberUS 11,857,550
TitleBenzathine analogs
Assignee(s)UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, United States Government As Represented By The Department Of Veterans Affairs